Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05569486 · ClinicalTrials.gov registry record · NA
Elucidating the Central Mechanisms of Action for Green Light Therapy in Managing Chronic Pain
A NA study, sponsored by University of Arizona.
- Not yet
- Registry status
- NA
- Development phase
- 70
- Enrollment target
NCT05569486 is a NA study that has not yet begun recruiting, run by University of Arizona. The registered enrollment target is 70 participants.
The verdict
NCT05569486, a NA study, has not yet begun recruiting, sponsored by University of Arizona.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
Study Summary
Investigators have previously shown that specific colors of light can alter nociception. Green light emitting diode exposure (GLED) provides long-lasting antinociception in rodents, through the visual system. No adverse effects were noted, and motor performance was not impaired. Investigator clinical trials have shown GLED is also effective in decreasing pain intensity of fibromyalgia patients and decreasing the number of headache-days per month in migraine patients. However, investigators do not yet understand the mechanisms by which GLED reduces pain. Understanding the mechanisms of action of GLED will provide additional support for using light therapy as both a treatment and as a possible diagnostic tool. While investigators do not fully understand the mechanisms of action of GLED, investigators do know that it is centrally mediated. To better elucidate the mechanism of action for GLED, investigators propose a single-blinded randomized placebo-controlled clinical trial to elucidate the central mechanism(s) of action that GLED therapy has in improving fibromyalgia pain, conducted by a team with a successful record of collaboration. Investigator's hypothesis is that GLED decreases neuroinflammation leading to modulation of the signaling in the ascending and descending pain pathways.
Interventions
- DEVICE Green Light
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2026-12-01 |
| Est. Completion | 2029-12-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05569486
The ClinicalTrials.gov registry entry for NCT05569486 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Arizona, which has 349 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Green Light is the first listed.
NCT05569486 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05569486 about?
NCT05569486 is a clinical study titled "Elucidating the Central Mechanisms of Action for Green Light Therapy in Managing Chronic Pain". Investigators have previously shown that specific colors of light can alter nociception. Green light emitting diode exposure (GLED) provides long-lasting antinociception in rodents, through the visual system. No adverse effects were noted, and motor performance was not impaired. Investigator clinica...
What is the current status of trial NCT05569486?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 70 participants. The study started on 2026-12-01. Estimated completion is 2029-12-30.
What interventions are being tested in trial NCT05569486?
The interventions under investigation include: Green Light (DEVICE).
Who is sponsoring clinical trial NCT05569486?
This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.